價格 | ¥3220 | ¥962 |
包裝 | 10mg | 1mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-12-12 |
中文名稱:化合物 OXSI-2 | 英文名稱:OXSI-2 |
CAS:622387-85-3 | 品牌: TargetMol |
產(chǎn)地: 美國 | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
產(chǎn)品類別: 抑制劑 | |
貨號: T28281 |
Name | OXSI-2 |
Description | OXSI-2 (Syk Inhibitor) is an inhibitor of Syk with an EC50 of 313 nM and an IC50 of 14 nM. OXSI-2 completely inhibits Adaptor protein LAT Y191 phosphorylation and Syk mediated events in platelets. |
In vitro | OXSI-2 (100 nM) does not affect the platelet functional responses induced by Convulxin, and modest shape change is still evident at 1 μM. OXSI-2 (2 μM) completely shape change and blocks GPVI-mediated dense granule release[2]. OXSI-2 (2 μM) inhibits pyroptotic cell death, inflammasome assembly, caspase-1 activation, IL-1β processing and release and mitochondrial ROS generation[3]. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Keywords | Inhibitor | Tyrosine | Potassium | Inflammasome | PAR | Pyroptosis | Src | kinase | Piceatannol | Syk | Spleen tyrosine kinase | inhibit | OXSI-2 | OXSI2 | signaling | GPVI | Inflammation |
Inhibitors Related | Cerdulatinib hydrochloride | Syk-IN-3 | PRT-060318 | ANTHRAQUINONE-2-CARBOXYLIC ACID | Ellagic acid | RO9021 | GSK1904529A | Cerdulatinib | Cevidoplenib dimesylate hydrochloride | R112 | R406 free base | PRT062607 hydrochloride |
成立日期 | 2013-04-18 (12年) | 注冊資本 | 566.265100萬人民幣 |
員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1億以上 |
主營行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學,分子砌塊,生物技術服務 | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
詢價 |
VIP1年
|
山東東德新材料有限公司
|
2024-12-17 | |
詢價 |
VIP1年
|
青島愷潤生物醫(yī)藥科技有限公司
|
2025-01-19 | |
詢價 |
VIP3年
|
陜西締都新材料有限公司
|
2024-12-18 |